Federal Budget 2018: $1.3b plan to make Australia a medical technology leader

Last night’s 2018 Federal budget saw a raft of funding and exciting initiatives aimed at further supporting Australia’s position as a global medical technology leader. Here’s how: Supporting Medical Research A 21st Century Medical Industry Growth Plan will deliver $1.3 billion to support Australia as a global health industry leader in medical technology, biotechnology and pharmaceuticals […]

More

Biotech vs The Budget 2019-20 video

Last week, Treasurer Josh Frydenberg announced the Morrison government’s Budget for 2019-20, should they win the federal election in May. In a newly released video, The iQ Group Global’s Senior Economist Laurence Parker-Brown explains the crucial changes needed to activate a thriving biotech industry in Australia – and why the industry cannot rely on government […]

More

iQGG In The Australian Financial Review

Dr George Syrmalis, Group CEO and Chairman of The iQ Group Global, is featured in The Australian Financial Review today. In the interview Dr Syrmalis discusses the evolution of biotech in China, outlines The Group’s plans to enter the Chinese market with the ground-breaking biosensor platform technology, and details the strategy behind The Group’s proposed […]

More

Dr George Syrmalis featured in CEO Magazine

Dr George Syrmalis, Group CEO of The iQ Group Global, is featured in the November edition of The CEO Magazine. In his interview ‘The Power of Practical Thinking’, Dr Syrmalis discusses his approach to leadership, outlines his vision for The Group’s future, and highlights the necessity for pragmatism in the biopharmaceutical industry. The article also […]

More